10:40 AM EDT, 05/23/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month price target by $9 to $51, based on a blended valuation (20x FY 27 EBITDA and 2.0x FY 27 EV/sales). We lift our FY 26 EPS to $1.24 from $1.19 and FY 27 to $1.50 from $1.44. CHWY is scheduled to report Q1 (Apr-Q) FY 26 results on June 11, and we continue to see upside on the shares. Net active customer growth appears to have reached an inflection point and is now likely to grow in the low-single-digit range this year. We also see opportunities for CHWY to capture greater share of wallet from pet parents, noting its net sales per active customer (NSPAC) stood at $578 in FY 25, while annual pet spending typically ranges from $1,200 to $2,500. Growth in Chewy+, vet clinics, and health/wellness should support NSPAC growth over many years, in our view. On the bottom line, CHWY has levers to expand margins, including areas like private label, health care, advertising, insurance, and automation. Lastly, CHWY has no long-term debt, is free cash flow positive, and has been actively repurchasing shares.